AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$662M
This Quarter Return
+52.92%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$662M
AUM Growth
+$662M
(+27%)
Cap. Flow
-$4.74M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
99.6%
Holding
13
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
|
$4.52M |
| 2 |
Spero Therapeutics
SPRO
|
$220K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$2.95B
| $214M | 32.26% | 4,896,462 | – | – |
|
2
Disc Medicine
IRON
$2.07B
| $126M | 19.07% | 2,384,456 | – | – |
|
3
Dyne Therapeutics
DYN
$1.92B
| $86.9M | 13.12% | 9,130,465 | – | – |
|
|
SION
4
Sionna Therapeutics, Inc. Common Stock
SION
$1.09B
| $64.1M | 9.68% | 3,694,020 | – | – |
|
|
THRD
5
DELISTED
Third Harmonic Bio
THRD
| $56.5M | 8.53% | 10,402,286 | – | – |
|
|
VIGL
6
DELISTED
Vigil Neuroscience
VIGL
| $46.4M | 7.01% | 5,836,874 | – | – |
|
7
Day One Biopharmaceuticals
DAWN
$769M
| $41.8M | 6.31% | 6,430,257 | – | – |
|
8
Korro Bio
KRRO
$217M
| $14.2M | 2.14% | 1,137,149 | – | – |
|
|
IMA
9
ImageneBio, Inc. Common Stock
IMA
$150M
| $6.72M | 1.02% | 5,018,178 | – | – |
|
10
Q32 Bio
QTTB
$20.9M
| $3.12M | 0.47% | 2,092,106 | – | – |
|
11
Generation Bio
GBIO
$40.4M
| $2.65M | 0.4% | 8,279,484 | – | – |
|
|
JBIO
12
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| – | – | -1,799,232 | Closed | -$4.52M |
|
|
13
Spero Therapeutics
SPRO
$116M
| – | – | -305,255 | Closed | -$220K |
|